In the spotlight

Gene Therapy Working Group

Aims

The EAHAD Gene Therapy Working Group was formed in 2019. The working group will strive to be at the forefront of providing critical information to physicians and patients about gene therapy in terms of practicability and safety.

Its goals are:

  • To investigate gene therapy safety and its outcome parameters.
  •  To provide updates on recent developments in terms of alanine aminotransferase (ALT) results and safety outcomes.
  •  To collect data on the different gene therapy trials, tests, and adverse events.
  •  To inform patients and medical professionals.

Latest Webinars

 

Members

Prof. Dr Wolfgang Miesbach

Chair

Germany

Prof. Ana Boban

Haematologist

Croatia

Dr Pratima Chowdary

Haematologist

United Kingdom

Dr Michiel Coppens

Haematologist

The Netherlands

Miguel Crato

EHC President

Portugal

Dr Robert Klamroth

Haematologist

Germany

Prof. Michael Makris

Haematologist

United Kingdom

Greta Mulders

Nurse

The Netherlands

Prof. Flora Peyvandi

Haematologist

Italy

Dr Víctor Jiménez-Yuste

Haematologist

Spain